Cited by 43Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Astrocytic uptake of neuronal corpses promotes cell‐to‐cell spreading of tau pathology

Open access
Mothes, Tobias, Portal, Benjamin, Konstantinidis, Evangelos, Eltom, Khalid, Libard, Sylwia, Streubel-Gallasch, Linn, Ingelsson, Martin, Rostami, Jinar +2 more·2023·Acta Neuropathologica Communications

Abstract

Tau deposits in astrocytes are frequently found in Alzheimer’s disease (AD) and other tauopathies. Since astrocytes do not express tau, the inclusions have been suggested to be of neuronal origin. However, the mechanisms behind their appearance and their relevance for disease progression remain unknown. Here we demonstrate, using a battery of experimental techniques that human astrocytes serve as an intermediator, promoting cell-to-cell spreading of pathological tau. Human astrocytes engulf and process, but fail to fully degrade dead neurons with tau pathology, as well as synthetic tau fibrils and tau aggregates isolated from AD brain tissue. Instead, the pathogenic tau is spread to nearby cells via secretion and tunneling nanotube mediated transfer. By performing co-culture experiments we could show that tau-containing astrocytes induce tau pathology in healthy human neurons directly. Furthermore, our results from a FRET based seeding assay, demonstrated that the tau proteoforms secreted by astrocytes have an exceptional seeding capacity, compared to the original tau species engulfed by the cells. Taken together, our study establishes a central role for astrocytes in mediating tau pathology, which could be of relevance for identifying novel treatment targets for AD and other tauopathies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-023-01589-8

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Astrocyte cell projections are critical for cellular communication and for the clearance of toxic oligomers such as tau.

    “Astrocyte cell projections, or extensions, are critical for cellular communication 29 and for the clearance of toxic oligomers such as tau. 30”

    From Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes (2025) · cites this paper as [30]

    Citation 30 is attached to the claim that astrocyte extensions clear toxic tau. The Discussion says astrocytes are unable to clear engulfed tau aggregates; instead, ineffective degradation promotes the cell-to-cell spread of pathological tau. The paper therefore makes the contrary point about clearance. (LLM, conf=0.89)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. [1]Ashraf GM Recent updates on the association between Alzheimer’s disease and vascular dementia Med Chem Shariqah United Arab Emir 2016 12 3 226 237 10.2174/1573406411666151030111820 26527156 · DOI
  2. [2]Selkoe DJ The molecular pathology of Alzheimer’s disease Neuron 1991 6 4 487 498 10.1016/0896-6273(91)90052-2 1673054 · DOI · Paper page
  3. [3]Hardy JA Higgins GA Alzheimer’s disease: the amyloid cascade hypothesis Science 1992 256 5054 184 185 10.1126/science.1566067 1566067 · DOI · Paper page
  4. [5]Weingarten MD Lockwood AH Hwo SY Kirschner MW A protein factor essential for microtubule assembly Proc Natl Acad Sci U S A 1975 72 5 1858 1862 10.1073/pnas.72.5.1858 1057175 PMC432646 · DOI · Paper page
  5. [6]Wood JG Mirra SS Pollock NJ Binder LI Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (?) Alzheimer Dis Assoc Disord 1987 1 3 203 10.1097/00002093-198701030-00021 PMC323661 2424015 · DOI
  6. [7]Grundke-Iqbal I Iqbal K Tung Y-C Quinlan M Wisniewski HM Binder LI Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology Alzheimer Dis Assoc Disord 1987 1 3 202 10.1097/00002093-198701030-00020 PMC323854 3088567 · DOI
  7. [8]Šimić G Tau protein hyperphosphorylation and aggregation in Alzheimer’s disease and other tauopathies, and possible neuroprotective strategies Biomolecules 2016 6 1 6 10.3390/biom6010006 26751493 PMC4808800 · DOI
  8. [9]Nolan A Astrocytic tau deposition is frequent in typical and atypical Alzheimer disease presentations J Neuropathol Exp Neurol 2019 78 12 1112 1123 10.1093/jnen/nlz094 31626288 PMC7967845 · DOI
  9. [10]Sofroniew MV Vinters HV Astrocytes: biology and pathology Acta Neuropathol (Berl) 2010 119 1 7 35 10.1007/s00401-009-0619-8 20012068 PMC2799634 · DOI · Paper page
  10. [11]Söllvander S Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons Mol. Neurodegener. 2016 10.1186/s13024-016-0098-z 27176225 PMC4865996 · DOI · Paper page
  11. [14]Konstantinidis E Dakhel A Beretta C Erlandsson A Long-term effects of amyloid-beta deposits in human iPSC-derived astrocytes Mol Cell Neurosci 2023 125 103839 10.1016/j.mcn.2023.103839 36907531 · DOI
  12. [15]Zyśk M Amyloid-β accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism J Neuroinflammation 2023 20 1 43 10.1186/s12974-023-02722-z 36803838 PMC9940442 · DOI
  13. [16]Konstantinidis E Portal B Mothes T Beretta C Lindskog M Erlandsson A Intracellular deposits of amyloid-beta influence the ability of human iPSC-derived astrocytes to support neuronal function J Neuroinflammation 2023 20 1 3 10.1186/s12974-022-02687-5 36593462 PMC9809017 · DOI
  14. [17]Rostami J Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain J Neuroinflammation 2020 17 1 119 10.1186/s12974-020-01776-7 32299492 PMC7164247 · DOI · Paper page
  15. [19]Patel H Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy Neurobiol Aging 2022 109 52 63 10.1016/j.neurobiolaging.2021.09.006 34655981 PMC8671336 · DOI
  16. [20]Wong C-O Endosomal-lysosomal processing of neurodegeneration-associated proteins in astrocytes Int J Mol Sci 2020 21 14 5149 10.3390/ijms21145149 32708198 PMC7404029 · DOI
  17. [21]Reid MJ Beltran-Lobo P Johnson L Perez-Nievas BG Noble W Astrocytes in tauopathies Front. Neurol. 2020 11 572850 10.3389/fneur.2020.572850 33071951 PMC7542303 · DOI
  18. [22]Lööv C Mitchell CH Simonsson M Erlandsson A Slow degradation in phagocytic astrocytes can be enhanced by lysosomal acidification Glia 2015 63 11 1997 2009 10.1002/glia.22873 26095880 PMC6728804 · DOI
  19. [24]Lundin A Human iPS-derived astroglia from a stable neural precursor state show improved functionality compared with conventional astrocytic models Stem Cell Rep 2018 10 3 1030 1045 10.1016/j.stemcr.2018.01.021 PMC5918339 29456185 · DOI
  20. [25]Falk A Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons PloS One 2012 7 1 e29597 10.1371/journal.pone.0029597 22272239 PMC3260177 · DOI
  21. [27]Shi Y Structure-based classification of tauopathies Nature 2021 598 7880 359 363 10.1038/s41586-021-03911-7 34588692 PMC7611841 · DOI · Paper page
  22. [29]Feltz CJ Miller GE An asymptotic test for the equality of coefficients of variation from k populations Stat Med 1996 15 6 647 658 10.1002/(SICI)1097-0258(19960330)15:6<647::AID-SIM184>3.0.CO;2-P 8731006 · DOI
  23. [31]Lööv C Hillered L Ebendal T Erlandsson A Engulfing astrocytes protect neurons from contact-induced apoptosis following injury PloS One 2012 7 3 e33090 10.1371/journal.pone.0033090 22461890 PMC3312890 · DOI
  24. [33]Harris JA Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits PLOS ONE 2012 7 9 e45881 10.1371/journal.pone.0045881 23029293 PMC3454317 · DOI
  25. [36]Köpke E Tung YC Shaikh S Alonso AC Iqbal K Grundke-Iqbal I Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease J Biol Chem 1993 268 32 24374 24384 10.1016/S0021-9258(20)80536-5 8226987 · DOI · Paper page
  26. [37]von Bergen M Friedhoff P Biernat J Heberle J Mandelkow EM Mandelkow E Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure Proc Natl Acad Sci U S A 2000 97 10 5129 5134 10.1073/pnas.97.10.5129 10805776 PMC25793 · DOI · Paper page
  27. [38]Hong M Chen DC Klein PS Lee VM Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3 J Biol Chem 1997 272 40 25326 25332 10.1074/jbc.272.40.25326 9312151 · DOI
  28. [39]Muñoz-Montaño JR Moreno FJ Avila J Diaz-Nido J Lithium inhibits Alzheimer’s disease-like tau protein phosphorylation in neurons FEBS Lett 1997 411 2–3 183 188 10.1016/s0014-5793(97)00688-1 9271202 · DOI
  29. [40]Pei JJ Tanaka T Tung YC Braak E Iqbal K Grundke-Iqbal I Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain J Neuropathol Exp Neurol 1997 56 1 70 78 10.1097/00005072-199701000-00007 8990130 · DOI · Paper page
  30. [41]Blalock EM Geddes JW Chen KC Porter NM Markesbery WR Landfield PW Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses Proc Natl Acad Sci U S A 2004 101 7 2173 2178 10.1073/pnas.0308512100 14769913 PMC357071 · DOI · Paper page
  31. [42]Li X Kumar Y Zempel H Mandelkow E-M Biernat J Mandelkow E Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration EMBO J 2011 30 23 4825 4837 10.1038/emboj.2011.376 22009197 PMC3243615 · DOI
  32. [43]Powell-Doherty RD Abbott ARN Nelson LA Bertke AS Amyloid-β and p-tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons J Virol 2020 94 9 e01874 e1919 10.1128/JVI.01874-19 32075924 PMC7163132 · DOI
  33. [44]Zempel H Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture J Biol Chem 2017 292 29 12192 12207 10.1074/jbc.M117.784702 28536263 PMC5519369 · DOI
  34. [45]Bengoa-Vergniory N Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease Acta Neuropathol Commun 2021 9 18 10.1186/s40478-020-01117-y 33509301 PMC7844979 · DOI
  35. [46]Kumar A Fontana IC Nordberg A Reactive astrogliosis: a friend or foe in the pathogenesis of Alzheimer’s disease J Neurochem 2021 10.1111/jnc.15565 34931315 · DOI · Paper page
  36. [47]Acioglu C Li L Elkabes S Contribution of astrocytes to neuropathology of neurodegenerative diseases Brain Res. 2021 1758 147291 10.1016/j.brainres.2021.147291 33516810 · DOI
  37. [48]Anderson MA Ao Y Sofroniew MV Heterogeneity of reactive astrocytes Neurosci Lett 2014 10.1016/j.neulet.2013.12.030 24361547 PMC3984948 · DOI
  38. [49]Kaniyappan S FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments Mol Neurodegener 2020 15 39 10.1186/s13024-020-00389-1 32677995 PMC7364478 · DOI

Cited by

Sorted by citations

Authors
Mothes, T., Portal, B., Konstantinidis, E., Eltom, K., Libard, S., Streubel-Gallasch, L., Ingelsson, M., Rostami, J., Lindskog, M., & Erlandsson, A.
Affiliations
Uppsala University (SE)
Corresponding author
Erlandsson, Anna
Venue
Acta Neuropathologica Communications
Published
2023-06-17
Volume
11
Issue
1
Pages
97-97
ISSN
2051-5960 (ISSN-L)
OpenAlex
W4381094183
Cited by
43
References
10
Citations by year
2026: 14 · 2025: 12 · 2024: 15 · 2023: 2
FWCI
7.64
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Alzheimerfonden (AF-968209)
  • Hjärnfonden (FO2021-0174)
  • Åhlén-stiftelsen (213021)
  • Stiftelsen för Gamla Tjänarinnor (2021-01171)
  • O. E. och Edla Johanssons Vetenskapliga Stiftelse (2021)
  • Stiftelsen Olle Engkvist Byggmästare (215-0399)
  • Gun och Bertil Stohnes Stiftelse (2021)
  • Vetenskapsrådet (2021-02563)
  • Uppsala University
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
astrocytes, tau pathology, Alzheimer's disease, tauopathy, cell-to-cell transmission, tunneling nanotubes, co-culture
MeSH terms
Alzheimer Disease, Astrocytes, Brain, Humans, Neurons, tau Proteins, Tauopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review